These are the companies that we have served, and they are very happy with our service

About Us

Abiosciences is the US headquarters of Analytical Biosciences, a single cell genomics company focusing on accelerating the development of novel therapeutics. Its mission is to unlock the mechanism of diseases through the most advanced translational single cell platforms with the largest, high-resolution databases, and the most comprehensive commercial grade data analytics. Led by science and data, the company has been and will continue to generate new knowledge and compile/organize insights for the identification and validation of novel cellular targets and biomarkers, which ultimately lead to next generation breakthrough therapeutics and diagnostics.

Webinars

View our webinars to learn about our latest ventures.

Visium Spatial Gene Expression for FFPE

Posted Mar 2022

In Vitro and In Silico Solutions

Posted Mar 2022

News

Breaking news and amazing progress in science and development of Abiosciences.

Dr. Su Zhang Joins Analytical BioSciences as Vice President of Global Strategy and Business Development

March 1, 2022, Analytical BioSciences (Abio) is pleased to announce that Dr. Su Zhang, a life sciences and pharmaceutical industry veteran, joins Abio as Vice President, Global Head of BD and Strategy. She will lead the pharmaceutical and biotechnology business partnerships and strategic development for the company.

Read more

Dr. Xiaodong Andy Huang is promoted as the Chief Scientific Officer (CSO) of Analytical BioSciences

Dr. Xiaodong Andy Huang, Senior Vice President of Analytical BioSciences (Abio), is promoted to Chief Scientific Officer (CSO) to lead the company's overall drug R&D work, also will lead the Shanghai Discovery and Development Center to continuously improve the company's drug R&D capabilities and further accelerate the development of our innovative drug pipeline and discovery platforms.

Read more

[Publication] Journal of Experimental Medicine | Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion

Jan 21th, 2022, Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is pleased to share that our client, Prof. Xinchun Chen’s group in Shenzhen University School of Medicine, has published a paper about tuberculous pleural effusion (TPE) in Journal of Experimental Medicine. Abio made great contributions to the single-cell data analysis part of the study.

Read more

Analytical BioSciences Releases OmniBrowser™ v3.1: A Powerful Data Exploration Platform with the Largest Multi-omics Single-cell Datasets Collection in the World

On December 21, 2021, Analytical BioSciences, a single-cell genomics and discovery company, released OmniBrowser™ v3.1, a new version of OmniBrowser™, providing more data and tools for single-cell data visualization and analysis to further empower innovative drug discovery and development.

Read more

Solutions

Abiosciences provide several single cell solutions for scientific research and drug discovery/development.

Join Us

We are looking for best talents to join us in this transforming enterprise of biology and medicine. We encourage you to learn more about our company and explore our opportunities. 

Read more >

logo
280 Utah Avenue Suite 110 South
San Francisco, CA 94080 United
Tel: +1-650-770-5619
E-mail: bd_us@abiosciences.com

© Analytical Biosciences Limited. All rights reserved.